Authors:
OEI SG
HELMERHORST FM
BLOEMENKAMP KWM
HOLLANTS FAM
MEERPOEL DEM
KEIRSE MJNC
Citation: Sg. Oei et al., EFFECTIVENESS OF THE POSTCOITAL TEST - RANDOMIZED CONTROLLED TRIAL, BMJ. British medical journal, 317(7157), 1998, pp. 502-505
Authors:
BLOEMENKAMP KWM
HELMERHORST FM
DERSJANTROORDA MD
DEBOER R
MEYER P
SPIELMANN D
KLUFT C
Citation: Kwm. Bloemenkamp et al., A COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150 MU-G DESOGESTREL COMBINEDWITH 20 MU-G ETHINYLESTRADIOL - EFFECT ON HEMOSTASIS, LIPID-METABOLISM AND CARBOHYDRATE-METABOLISM, Gynecological endocrinology, 12, 1998, pp. 21-30
Authors:
BLOEMENKAMP KWM
ROSENDAAL FR
HELMERHORST FM
KOSTER T
BERTINA RM
VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 80(3), 1998, pp. 382-387
Authors:
BLOEMENKAMP KWM
ROSENDAAL FR
HELMERHORST FM
KOSTER T
BERTINA RM
VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO HAD PREVIOUSLYDEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 1997, pp. 786-786
Citation: Kwm. Bloemenkamp et al., THE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVES AND VENOUS THROMBOSIS IS NOT EXPLAINED BY DIAGNOSTIC SUSPICION AND REFERRAL BIAS, Thrombosis and haemostasis, 1997, pp. 2903-2903
Authors:
HELMERHORST FM
BLOEMENKAMP KWM
ROSENDAAL FR
VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., ORAL-CONTRACEPTIVES AND THROMBOTIC DISEASE - RISK OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 78(1), 1997, pp. 327-333
Authors:
OEI SG
HELMERHORST FM
BLOEMENKAMP KWM
DERSJANTROORDA M
KEIRSE MJNC
Citation: Sg. Oei et al., PREDICTING OPTIMAL CERVICAL-MUCUS FOR INFERTILITY DIAGNOSIS, European journal of obstetrics, gynecology, and reproductive biology, 73(1), 1997, pp. 63-66
Authors:
VANDENBROUCKE JP
HELMERHORST FM
BLOEMENKAMP KWM
ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., 3RD-GENERATION ORAL-CONTRACEPTIVE AND DEEP VENOUS THROMBOSIS - FROM EPIDEMIOLOGIC CONTROVERSY TO NEW INSIGHT IN COAGULATION, American journal of obstetrics and gynecology, 177(4), 1997, pp. 887-891
Authors:
OEI SG
BLOEMENKAMP KWM
HELMERHORST FM
NAAKTGEBOREN N
KEIRSE MJNC
Citation: Sg. Oei et al., EVALUATION OF THE POSTCOITAL TEST FOR ASSESSMENT OF CERVICAL FACTOR INFERTILITY, European journal of obstetrics, gynecology, and reproductive biology, 64(2), 1996, pp. 217-220
Authors:
VANDENBROUCKE JP
BLOEMENKAMP KWM
HELMERHORST FM
ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., MORTALITY FROM VENOUS THROMBOEMBOLISM AND MYOCARDIAL-INFARCTION IN YOUNG-WOMEN IN THE NETHERLANDS, Lancet, 348(9024), 1996, pp. 401-402
Authors:
OEI SG
HELMERHORST FM
BLOEMENKAMP KWM
KEIRSE MJNC
Citation: Sg. Oei et al., EFFECT OF THE POSTCOITAL TEST ON THE SEXUAL RELATIONSHIP OF INFERTILECOUPLES - A RANDOMIZED CONTROLLED TRIAL, Fertility and sterility, 65(4), 1996, pp. 771-775
Citation: Kwm. Bloemenkamp et al., ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN, Lancet, 346(8990), 1995, pp. 1593-1596